Healthcare provider profile · identity verified

Wayne E Grayson, MD

Family Practice · CARRIERE, MS · NPI 1437169521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	577	160
Amlodipine Besylate	Amlodipine Besylate	533	152
Losartan Potassium	Losartan Potassium	432	122
Rosuvastatin Calcium	Rosuvastatin Calcium	399	120
Lisinopril	Lisinopril	335	95
Levothyroxine Sodium	Levothyroxine Sodium	301	75
Metoprolol Succinate	Metoprolol Succinate	250	64
Hydrochlorothiazide	Hydrochlorothiazide	220	66
Gabapentin	Gabapentin	184	46
Glimepiride	Glimepiride	164	46
Omeprazole	Omeprazole	159	44
Metformin Hcl	Metformin Hcl	156	50
Pantoprazole Sodium	Pantoprazole Sodium	153	48
Potassium Chloride	Potassium Chloride	114	29
Escitalopram Oxalate	Escitalopram Oxalate	109	27
Furosemide	Furosemide	108	30
Jardiance	Empagliflozin	101	13
Metformin Hcl Er	Metformin Hcl	93	24
Fluticasone Propionate	Fluticasone Propionate	91	29
Allopurinol	Allopurinol	89	26
Metoprolol Tartrate	Metoprolol Tartrate	89	27
Sertraline Hcl	Sertraline Hcl	85	22
Simvastatin	Simvastatin	82	23
Tamsulosin Hcl	Tamsulosin Hcl	82	25
Pravastatin Sodium	Pravastatin Sodium	81	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	21
Albuterol Sulfate Hfa	Albuterol Sulfate	77	22
Meloxicam	Meloxicam	74	26
Carvedilol	Carvedilol	72	24
Citalopram Hbr	Citalopram Hydrobromide	65	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	19
Amitriptyline Hcl	Amitriptyline Hcl	60	15
Duloxetine Hcl	Duloxetine Hcl	60	15
Trazodone Hcl	Trazodone Hcl	59	17
Alendronate Sodium	Alendronate Sodium	55	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	13
Clonidine Hcl	Clonidine Hcl	51	15
Bupropion Xl	Bupropion Hcl	50	14
Indapamide	Indapamide	49	14
Atenolol	Atenolol	47	11
Buspirone Hcl	Buspirone Hcl	47	13
Clonazepam	Clonazepam	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	46	36
Eliquis	Apixaban	44	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Tramadol Hcl	Tramadol Hcl	43	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Montelukast Sodium	Montelukast Sodium	40	12
Tizanidine Hcl	Tizanidine Hcl	40	11
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	14
Valsartan	Valsartan	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Trulicity	Dulaglutide	32	suppressed
Ozempic	Semaglutide	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Baclofen	Baclofen	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Famotidine	Famotidine	27	suppressed
Finasteride	Finasteride	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Glipizide	Glipizide	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Linzess	Linaclotide	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Azithromycin	Azithromycin	17	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Ezetimibe	Ezetimibe	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Methylprednisolone	Methylprednisolone	15	11
Novolin N	Insulin Nph Human Isophane	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Prednisone	Prednisone	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Guanfacine Hcl	Guanfacine Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Ramipril	Ramipril	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mitigare	Colchicine	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error